Sildenafil NDC 59746-434

NDC codes

FDA NDC Directory

Product NDC (as listed)59746-434Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59746-0434Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59746-434-03	59746043403	100 TABLET, FILM COATED in 1 CARTON (59746-434-03)Marketed from Sep 1, 2026
59746-434-04	59746043404	10 TABLET, FILM COATED in 1 BLISTER PACK (59746-434-04)Marketed from Sep 1, 2026
59746-434-05	59746043405	500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-434-05)Marketed from Sep 1, 2026
59746-434-30	59746043430	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-434-30)Marketed from Sep 1, 2026
59746-434-90	59746043490	90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-434-90)Marketed from Sep 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sildenafil
Generic name (nonproprietary): sildenafil
Active ingredients: Sildenafil citrate — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Jubilant Cadista Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201156
Marketing start: Sep 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers: Product ID 59746-434_4bcef8ac-9715-407e-a23c-ed036c8827c8SPL ID 4bcef8ac-9715-407e-a23c-ed036c8827c8SPL set ID 1ed2420b-478a-ca9c-0330-85c845acdd32RxCUI 312950, 314228, 314229UNII BW9B0ZE037UPC 0359746436308, 0359746436018, 0359746435301, 0359746434304, 0359746435011
Pharmacologic class: Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459746043403 followed by a unit qualifier and the quantity

Package 59746-0434-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 3, 2026.

Indications (excerpt from the label)

Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil tablets are phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201156

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201156
Product	Strength	Form · route	Labeler	Product NDC
Sildenafil	Sildenafil citrate 100 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmaceuticals Inc.	59746-436
Sildenafil	Sildenafil citrate 50 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmaceuticals Inc.	59746-435